Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001730728-19-000001
Filing Date
2019-12-27
Accepted
2019-12-27 14:54:53
Documents
1
Effectiveness Date
2019-12-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6491
  Complete submission text file 0001730728-19-000001.txt   7702
Mailing Address 841 EAST FAYETTE STREET SYRACUSE NY 13210
Business Address 841 EAST FAYETTE STREET SYRACUSE NY 13210 401-699-9402
ZETAGEN THERAPEUTICS, INC. (Filer) CIK: 0001730728 (see all company filings)

EIN.: 473365449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-356559 | Film No.: 191313440